Pentoxifylline ameliorates renal tumor necrosis factor expression, sodium retention, and renal hypertrophy in diabetic rats.
about
Diabetic kidney disease: from physiology to therapeuticsDiabetic Kidney Disease: Pathophysiology and Therapeutic TargetsInflammation in diabetic kidney diseaseInterleukin-6 stimulates epithelial sodium channels in mouse cortical collecting duct cellsInflammatory cytokines in diabetic nephropathy.Effects of combination of aliskiren and pentoxyfylline on renal function in the rat remnant kidney model of chronic renal failure.Pentoxifylline reduces the inflammatory process in diabetic rats: relationship with decreases of pro-inflammatory cytokines and inducible nitric oxide synthasePathophysiological role and therapeutic implications of inflammation in diabetic nephropathyTNF-α mediates increased susceptibility to ischemic AKI in diabetes.Proinsulin C-peptide: friend or foe in the development of diabetes-associated complications?Microinflammation in the pathogenesis of diabetic nephropathy.Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury.6. Diabetic NephropathyThe effects of pentoxifylline into the kidneys of rats in a model of unilateral hindlimb ischemia/reperfusion injury.Therapeutic efficacy of pentoxifylline on proteinuria and renal progression: an update.Calcium dobesilate may alleviate diabetes‑induced endothelial dysfunction and inflammation.Role of the TNF pathway in the progression of diabetic nephropathy in KK-A(y) mice.Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration.
P2860
Q27021392-30C1862B-2F5C-4568-8FA0-59AA3CC3EB3FQ28086840-60BAACAC-39BD-4CF2-A5B7-E28562D193D1Q34023543-2BEA074C-03F1-49B1-8455-60ACB4E4D92DQ34085605-B350AA02-C798-43C3-9A09-C75E8DB2BE2BQ35133177-5A373078-7595-4D2A-93AD-4D0D10A5BDE1Q35222407-D8A95B4C-B11C-4607-BB44-81F0CDD97795Q35544336-0E254C91-35E9-4EC7-B463-6B9AB7726D39Q35673446-881D8B39-D776-4601-A2BD-226534CDA604Q36699862-29AE75E9-6A21-4A26-9C71-043B0140431AQ37428866-4BDEAC73-10D5-492B-AA75-A6C346174ECBQ38213048-CE195EB1-580B-4580-9F25-E4FCE564975FQ38936622-0F93D946-19AF-43A6-A08A-53BD1E40E73AQ41559116-C43CE59B-B365-453E-96B1-39EA7044C963Q42378585-0165A501-69D0-45FD-AFEB-DB769EA34956Q46751469-05C4D4F4-5CA0-4DF6-A4AB-F41A4A6EFACDQ47408441-65BD98C9-CFE8-40D8-9BA3-DBAE6F95804FQ47641666-37ED382C-58C7-4851-9D83-34C1010E5F47Q53061535-31071F4F-7656-4133-BCDD-830E786CE798Q54567389-C48ED7D9-704E-4C6B-A678-B9256453E25B
P2860
Pentoxifylline ameliorates renal tumor necrosis factor expression, sodium retention, and renal hypertrophy in diabetic rats.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Pentoxifylline ameliorates ren ...... hypertrophy in diabetic rats.
@en
Pentoxifylline ameliorates ren ...... hypertrophy in diabetic rats.
@nl
type
label
Pentoxifylline ameliorates ren ...... hypertrophy in diabetic rats.
@en
Pentoxifylline ameliorates ren ...... hypertrophy in diabetic rats.
@nl
prefLabel
Pentoxifylline ameliorates ren ...... hypertrophy in diabetic rats.
@en
Pentoxifylline ameliorates ren ...... hypertrophy in diabetic rats.
@nl
P356
P1476
Pentoxifylline ameliorates ren ...... hypertrophy in diabetic rats.
@en
P2093
Frank A Gesek
Keith DiPetrillo
P304
P356
10.1159/000079121
P577
2004-05-01T00:00:00Z